China Health Holding Retains Investor Relations International for Strategic IR Effort.

LAS VEGAS -- China Health Holding (OTCBB:CHHH), a developer, marketer and manufacturer of natural herbal supplement products based on traditional Chinese medicine, today announced that it has retained Investor Relations International (IRI) to lead an expanded shareholder communication program.

As investor relations counsel for China Health, Los Angeles-based IRI will raise investor awareness of the company's performance through a multi-channel campaign. IRI will employ print and electronic media as well as direct communication with money managers and current or prospective shareholders. The IRI program, focused on communicating China Health's expansion strategy across China, seeks both to broaden the Company's shareholder base and to solidify the long-term loyalty of current shareholders.

"We are pleased to have Investor Relations International supporting our efforts to better communicate with our existing shareholders while simultaneously increasing our efforts to attract new investors familiar with our current robust expansion and our prospects for future growth," said Julianna Lu, President and CEO of China Health Holding. "With the rapidly increasing interest in herbal products, global demand for our unique and effective herbal medicinal products and Major China Pharmaceutical Acquisitions has never been stronger.

"The one crucial element we have lacked up to this point is a strong investor-relations program to raise our profile on Wall Street and give us better access to the capital markets should we require it. Our retention of IRI fills that gap, and we expect to benefit from much greater visibility and liquidity from here on."

If you would like to be added to China Health's investor email lists or have additional questions, please contact Haris Tajyar with Investor Relations International at [e-mail].

About China Health Holding, Inc.

China Health Holding, Inc. uses traditional Chinese medicine to develop, manufacture, and commercialize natural herbal medicinal products, natural multi-vitamins and mineral food supplements. The Company is currently focusing on penetrating the lucrative Chinese market where it can leverage its brand-name and strategic relationships to support its expansion plan. The Company's further comprehensive strategy plan is to develop and complete pharmaceutical acquisitions with major pharmaceutical companies in PR China and worldwide to vertically integrate its operations from manufacturing, developing and marketing Chinese herbal based medicinal products, as well as a comprehensive pharmaceutical drug pipeline, to full distribution and marketing across PR China, therefore substantially increasing its profit margins. Acquisitions will accelerate the company's growth of revenues and earnings power. A strategic combination of assets, net income, an enhanced pharmaceutical drug pipeline and technologies will accrete value to the Company and its shareholders and secure a strong powerful position in pharmaceutical industry in PR China and worldwide. For more information in China Health Holding, please visit our website at www.chinahealthholding.com.

About Investor Relations International

Investor Relations International (IRI), based in Los Angeles, is a leading investor relations firm serving a worldwide client base. The principals of IRI have developed award-winning investor relations programs for a number of NYSE and Nasdaq-listed companies such as Insmed Inc., Internet Capital Group, LJ International, Starwood Hotels & Resorts Worldwide, ValueVision International and others, and have assisted dozens of public companies ranging from emerging small-cap companies to multinational corporations with market capitalizations in excess of $15 billion. IRI designs and implements customized investor relations programs to meet each client's unique needs. It enjoys one of the highest client retention rates in the industry.

Forward-Looking Statements

To the extent that statements in the press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward looking, all forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all of the Company's press releases to reflect events or circumstances after the date hereof.